Ambeed.cn

首页 / 抑制剂/激动剂 / / GHSR / JMV 2959 HCl

JMV 2959 HCl {[allProObj[0].p_purity_real_show]}

货号:A1961316

JMV 2959 hydrochloride是一种 GHS-R1a 型生长激素促分泌素受体的拮抗剂,IC50 为 32 nM,常用于内分泌和代谢疾病的研究。

JMV 2959 HCl 化学结构 CAS号:2448414-54-6
JMV 2959 HCl 化学结构
CAS号:2448414-54-6
JMV 2959 HCl 3D分子结构
CAS号:2448414-54-6
JMV 2959 HCl 化学结构 CAS号:2448414-54-6
JMV 2959 HCl 3D分子结构 CAS号:2448414-54-6
规格 价格 会员价 库存 数量
{[ item.pr_size ]} {[ size_append(item.pr_size_append, item.pr_am, item.pr_size) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

JMV 2959 HCl 纯度/质量文件 产品仅供科研

货号:A1961316 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025, 188, (21): 5847-5861.e11. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025, 20, 1502-1513. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >

JMV 2959 HCl 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
Mice D1R-mediated kindling model Intraperitoneal injection 5 mg/kg Administered 30 min prior to each SKF81297 injection, observed for 45 min Evaluate the effects of JMV-2959 on seizures in the D1R-mediated kindling model, showing no differences in seizure severity and number. Int J Mol Sci. 2019 May 20;20(10):2480
Rats Conditioned place preference (CPP), intravenous self-administration (IVSA), and behavioral stimulation models Intraperitoneal injection 1 or 3 mg/kg Single or repeated administration, lasting for 8 days (CPP) or 3 days (IVSA) JMV2959 significantly and dose-dependently reduced THC-induced conditioned place preference and behavioral stimulation, as well as WIN55,212-2 intravenous self-administration and relapse-like behavior Int J Mol Sci. 2021 Feb 27;22(5):2397
Rats Conditioned place preference (CPP) and intravenous self-administration (IVSA) models Intraperitoneal injection 1, 3, and 6 mg/kg Single or multiple administrations, experiments conducted 20 minutes after each administration JMV2959 significantly reduced methamphetamine-induced conditioned place preference (CPP) expression and decreased methamphetamine intravenous self-administration (IVSA) and relapse-like behavior. Int J Mol Sci. 2018 Sep 26;19(10):2925
Rats Opioid-induced changes in dopamine, endocannabinoids, and GABA concentrations in the nucleus accumbens shell model Intraperitoneal, VTA injection, or NAC perfusion 3 mg/kg (i.p.) or 2 µg/10 µg (VTA) or 8 mM/40 mM (NAC perfusion) Single administration, monitored for 3 hours JMV2959 pre-treatment significantly reversed fentanyl-induced anandamide increases in the NACSh, resulting in a significant AEA decrease and intensified fentanyl-induced decreases in accumbens 2-AG levels, while also reducing fentanyl-evoked GABA efflux and behavioral stimulation. Int J Mol Sci. 2017 Nov 22;18(11):2486
Rat Wistar rats Intraperitoneal injection 3 mg/kg Single administration To investigate the effects of JMV2959 on WIN55,212-2-induced behavioral stimulation and dopamine release in the nucleus accumbens. Results showed that JMV2959 significantly reduced WIN55,212-2-induced behavioral stimulation and dopamine release in the nucleus accumbens. Int J Mol Sci. 2020 Dec 28;22(1):210
Mice and rats Alcohol dependence models Intraperitoneal injection 9 mg/kg (mice) and 1, 2, 4 mg/kg (rats) Once daily for 5 days (mice) and twice weekly for 7 days (rats) JMV2959 reduced ethanol intake but did not affect ethanol preference. In rats, JMV2959 reduced operant self-administration of both ethanol and sucrose. Neuropharmacology. 2015 Oct;97:182-93

JMV 2959 HCl 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.83mL

0.37mL

0.18mL

9.17mL

1.83mL

0.92mL

18.35mL

3.67mL

1.83mL

JMV 2959 HCl 技术信息

CAS号2448414-54-6
分子式C30H33ClN6O2
分子量 545.08
SMILES Code O=C(N[C@@H](C1=NN=C(CCC2=CC=CC=C2)N1CC3=CC=C(OC)C=C3)CC4=CNC5=C4C=CC=C5)CN.[H]Cl
MDL No. MFCD31715444
别名
运输蓝冰
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Inert atmosphere, 2-8°C

溶解方案

DMSO: 250 mg/mL(458.65 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

H2O: 25 mg/mL(45.87 mM),配合低频超声助溶

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
方案 三
配制的工作液建议现用现配,短期内尽快用完。 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。